Aromatase deficiency is a rare genetic condition that affects how the body makes estrogen. People with aromatase deficiency usually have lifelong signs that begin before birth, in childhood, or around puberty, and the features can differ by sex and age. Common features include atypical genital development in some female babies, delayed or absent puberty, continued growth with very tall height, weak bones, and trouble with fertility. Not everyone will have the same experience. Treatment often includes hormone replacement, especially estrogen, along with monitoring of growth, bone health, and reproductive health, and people with aromatase deficiency can often do well with ongoing care.
How many people live with Aromatase deficiency?
Aromatase deficiency is thought to affect fewer than 1 in 1,000,000 people, which suggests that fewer than about 8,000 people may be living with it worldwide (Orphanet, 2024; United Nations, 2024). Using that same rate, fewer than about 340 people in the United States may be living with aromatase deficiency, although this is an estimate rather than a direct count (Orphanet, 2024; U.S. Census Bureau, 2024).
Overview
Aromatase deficiencySymptoms
Aromatase deficiency can affect growth, puberty, and fertility. In girls, features often include ambiguous genitals at birth and delayed puberty. Early symptoms of aromatase deficiency in boys may include tall height, ongoing growth, and weak bones.
Outlook and prognosis
With aromatase deficiency, outlook depends on age, sex, and whether treatment starts early. Many people do well with hormone care and regular follow-up, which can support growth, bone strength, puberty, fertility, and day-to-day health.
Causes and risk factors
Aromatase deficiency is caused by changes in the CYP19A1 gene, usually inherited from both parents. It can also happen as a new genetic change. Lifestyle or environmental factors do not cause it, but may affect complications.
Genetic influences
Genetics are central to aromatase deficiency. It is usually caused by changes in the CYP19A1 gene, and different genetic variants can affect how severe aromatase deficiency is and when symptoms first appear.
Diagnosis
Aromatase deficiency is usually suspected from clinical features and hormone test results. The diagnosis of Aromatase deficiency is confirmed with genetic testing, and sometimes imaging helps assess differences in the ovaries, testes, or bones.
Treatment and drugs
Aromatase deficiency is often treated with estrogen replacement, especially for girls and women, to support puberty and bone strength. Many with aromatase deficiency also need regular checks of growth, hormones, and blood sugar. Some may need fertility care or surgery.
Symptoms
Aromatase deficiency often affects puberty, growth, and bone strength in ways that can be confusing at first. In daily routines, this might show up as puberty changes that do not unfold as expected, taller-than-expected growth, or fractures after a minor fall. The early features of aromatase deficiency can be obvious at birth in some girls, while in boys they may be subtle and sometimes are not recognized until later childhood or adulthood.
In babies assigned female at birth, the outer genitals may look more typical of a boy or may appear in between, such as a larger clitoris or partly fused skin folds. Babies assigned male at birth usually do not have obvious genital differences.
Many living with aromatase deficiency who are assigned female at birth do not go through puberty in the usual way because estrogen stays very low. Breast development may be limited or absent, and menstrual periods may not start.
Extra male-type hormones can cause more facial or body hair, acne, or a deeper voice, especially in people assigned female at birth. These changes may become more noticeable in the teen years.
Some people with aromatase deficiency have enlarged ovaries or ovarian cysts, which can cause pelvic discomfort or make monthly cycles irregular. Trouble ovulating and infertility can happen later.
How people usually first notice Aromatase deficiency?
How aromatase deficiency is first noticed depends on whether it affects a fetus, a newborn, or a child, but the earliest clues often appear before or at birth. In a baby assigned female at birth, doctors may notice genital differences such as genitalia that look more typically male, while during pregnancy the birth mother may develop signs of higher testosterone, such as acne, deeper voice, or increased facial hair, because the placenta cannot convert these hormones normally. In babies assigned male at birth, the condition may be harder to spot early, and the first signs of aromatase deficiency may not become clear until later childhood or puberty, when growth, bone maturation, or pubertal development do not follow the usual pattern.
Types of Aromatase deficiency
No distinct types of Aromatase deficiency are widely recognized.
Can I slow down the onset of symptoms?
In general, no—because aromatase deficiency is a rare inherited condition that is present before birth, there is no good evidence that lifestyle changes like diet, exercise, sleep, or supplements can meaningfully delay when symptoms begin. What can help is early care with a hormone specialist, because treatment to replace the missing hormone estrogen is a well-established option that can improve puberty, bone strength, growth, and some later health problems, but it does not prevent the condition itself. Even though you cannot stop aromatase deficiency from occurring, an early diagnosis and regular follow-up may help reduce complications over time.
What genetics can tell you about symptoms
Genetics can help explain why aromatase deficiency can look different from one person to another, because different changes in the CYP19A1 gene can affect how much aromatase enzyme the body is still able to make. In general, gene changes that reduce enzyme activity more severely are linked with earlier and more noticeable hormone-related features, while changes that leave a little activity can lead to milder symptoms or a later diagnosis. Even so, genetics does not predict every detail, and people with the same condition can still have different symptoms, severity, and timing.
Causes and risk factors
Aromatase deficiency is caused by changes in the CYP19A1 gene, which means the body cannot make enough of the enzyme that helps turn certain hormones into estrogen. It is usually inherited when a child receives one changed copy of the gene from each parent, so family history and parents who are blood relatives can raise the chance. Biological factors such as sex, age, and hormone levels can affect when aromatase deficiency shows up and how severe it is. Lifestyle and environmental factors do not cause aromatase deficiency, but they can influence related issues such as bone strength, growth, and fertility. Genetic testing for aromatase deficiency can sometimes clarify your personal risk.
What are the most common causes or risk factors?
Aromatase deficiency is almost always caused by inherited changes in a gene called CYP19A1, which helps the body make an enzyme needed to turn certain hormones into estrogen. The main risk factor is being born to two parents who both carry a changed copy of this gene, so it may be more likely in families with a history of the condition or when the parents are blood relatives. There are no well-known lifestyle or environmental causes.
Environmental and biological risk factors
When people look up risk factors for aromatase deficiency, it helps to know that there are no well-proven environmental triggers such as infections, medicines, or pollution. Doctors often group risks into internal (biological) and external (environmental). For aromatase deficiency, the established risks are mainly biological and are usually present before conception, most often when both biological parents carry the same rare CYP19A1 change.
Aromatase deficiency usually happens when a baby inherits a nonworking CYP19A1 copy from each biological parent. The parents are often healthy themselves, so there may be no clear warning signs in the family.
If biological parents are related by blood or come from a small, closely connected community, they may be more likely to carry the same rare CYP19A1 change. This can raise the chance of aromatase deficiency in a pregnancy.
A brother, sister, or earlier pregnancy affected by aromatase deficiency can point to a higher chance in future pregnancies. This is because the same parental carrier pattern may be present each time.
No common environmental exposure, maternal illness, or birth event has been clearly shown to cause aromatase deficiency. For many families, this means it is not linked to anything they did or did not do during pregnancy.
Genetic risk factors
For many living with aromatase deficiency, the underlying problem starts before birth because the body cannot make enough aromatase, an enzyme that helps keep sex hormones in balance. The genetic causes of aromatase deficiency almost always involve changes in the CYP19A1 gene. Some risk factors are inherited through our genes. Most cases happen when a child inherits one nonworking copy of this gene from each parent.
CYP19A1 changes: Aromatase deficiency is caused by harmful changes in CYP19A1, the gene that helps the body make the aromatase enzyme. When both copies do not work well enough, estrogen levels drop and hormone balance shifts.
Two altered copies: Most people with aromatase deficiency inherit two altered copies of CYP19A1, one from each parent. This pattern is called autosomal recessive, which means one altered copy alone usually does not cause the condition.
Carrier parents: Parents who each carry one altered CYP19A1 copy usually do not have symptoms themselves. For each pregnancy, there is a 25% chance of having a child with aromatase deficiency and a 50% chance the child will be a carrier.
Family history: A family history of aromatase deficiency can be an important clue that the gene change runs in the family. This is especially relevant if a brother, sister, or other close relative has been diagnosed.
Related parents: When parents are biologically related, there is a higher chance they carry the same rare CYP19A1 change. That makes autosomal recessive conditions like aromatase deficiency more likely in their children.
Variant type: Not all CYP19A1 changes affect the gene in exactly the same way. Some leave a little enzyme activity, while others block it almost completely, which can influence how early and how strongly symptoms appear.
Lifestyle risk factors
Aromatase deficiency is a genetic condition, so lifestyle habits do not cause it. However, how lifestyle affects aromatase deficiency can be important for bone strength, metabolic health, pubertal development support, and long-term complications. The main lifestyle risk factors for aromatase deficiency are those that worsen low-estrogen effects or add extra strain to bones and cardiometabolic health.
In aromatase deficiency, very low estrogen can reduce bone mineralization, so poor calcium intake may further weaken bones. Diets low in dairy, fortified foods, or other calcium-rich foods can increase the risk of osteopenia, osteoporosis, or fractures over time.
Vitamin D helps the body absorb calcium, which is especially important when aromatase deficiency is already impairing bone health. Limited vitamin D intake can make low bone density and skeletal complications more likely.
Too little weight-bearing or resistance exercise may worsen the bone fragility linked to aromatase deficiency. Regular muscle-strengthening and impact activity can help support bone density, balance, and physical function.
Higher body fat can add to insulin resistance, abnormal lipids, and fatty liver risk, which may already need close attention in people with aromatase deficiency. In this way, lifestyle risk factors for aromatase deficiency include patterns that promote weight gain and poor metabolic health.
Risk prevention
For people with aromatase deficiency, preventing the condition itself is usually not possible because it is a rare genetic disorder present from birth. Prevention mainly means lowering the risk of complications, such as bone weakness, delayed or unusual puberty changes, growth problems, and fertility-related issues. Many living with aromatase deficiency do best with regular specialist care so changes are picked up early, often before they start affecting daily life. Prevention is flexible—it adapts to your life and health background.
Ongoing care with an endocrinologist can help catch hormone-related changes early and lower the risk of long-term complications from aromatase deficiency. Regular visits often include growth checks, puberty monitoring, and review of symptoms that may affect school, work, or daily comfort.
When prescribed, hormone replacement can help support more typical bone, growth, and puberty development in people with aromatase deficiency. Taking treatment as directed and reviewing doses over time may help prevent some of the most important complications.
Low estrogen levels can weaken bones over time, so bone health needs close attention in aromatase deficiency. Weight-bearing activity, enough calcium and vitamin D, and bone density testing may help reduce the risk of fractures and early bone loss.
Children and teens with aromatase deficiency may need careful tracking of height, bone age, and pubertal development. This can help doctors respond early if there are signs linked to the early symptoms of aromatase deficiency, such as unusual growth patterns or delayed body changes.
Can you prevent Aromatase deficiency?
No, aromatase deficiency usually cannot be prevented because it is a very rare condition caused by an inherited change in a gene, not by anything a parent did or did not do. If this condition runs in your family, genetic counseling before pregnancy may help you understand the chances of passing it on, but it cannot fully prevent the condition.
Transmission
Aromatase deficiency is not infectious, so it cannot be caught from another person through touch, coughing, sex, food, or blood. Instead, the genetic transmission of Aromatase deficiency happens from parent to child through changes in a gene involved in making estrogen.
Most often, Aromatase deficiency is inherited in an autosomal recessive pattern, which means a child must receive one changed copy of the gene from each parent. When both parents are carriers, each pregnancy has a 25% chance of the child having the condition, a 50% chance of being a carrier, and a 25% chance of inheriting neither changed copy.
When to test your genes
Consider genetic testing when a baby has atypical genital development, when the birth mother developed unusual acne, deepening voice, or excess hair during pregnancy, or when a child later shows delayed puberty, continued growth without normal bone maturation, or unexplained high androgen levels. Confirming aromatase deficiency can guide hormone treatment and bone care early.
Diagnosis
Aromatase deficiency is usually suspected when a baby, child, or adult has a pattern of hormone-related features that does not fit the usual course of development. In many living with aromatase deficiency, diagnosis starts with differences in sexual development, delayed or unusual puberty, ongoing growth after the usual age, or infertility. Doctors usually begin with a careful exam and hormone testing, then confirm the diagnosis with more specific studies. Getting a diagnosis is often a turning point toward answers and support.
Doctors look at physical signs present at birth or that appear later, such as differences in genital development, delayed puberty, tall height with continued growth, or trouble with fertility. In a pregnant parent carrying an affected baby, excess male-type hormone effects during pregnancy can also be an important clue.
Blood tests measure estrogen, testosterone, and related hormones to see whether the body is making very little estrogen. This part of the diagnosis of aromatase deficiency often shows a hormone pattern that strongly suggests the condition.
X-rays can show that bone growth plates stay open longer than expected, which helps explain continued growth into later teen or adult years. Bone density testing may also be done because low estrogen can weaken bones over time.
Pelvic ultrasound may be used to look at the ovaries, uterus, or testes, depending on the person’s age and anatomy. These imaging findings can help explain symptoms and support the overall clinical picture.
How is Aromatase deficiency diagnosed?
Doctors usually diagnose aromatase deficiency by looking at a person’s symptoms and development over time, including differences in sex development at birth, delayed or unusual puberty, and blood tests that show very low estrogen with higher-than-expected testosterone or other male-type hormones. They may also use imaging, such as a pelvic ultrasound, to look at the ovaries, uterus, or bones and to rule out other causes. A genetic test can help confirm the diagnosis by finding a change in the gene that the body uses to make estrogen.
Stages of Aromatase deficiency
Aromatase deficiency does not have defined progression stages. This is because it is a lifelong genetic condition that is identified by its hormone effects and physical features, rather than by a steady step-by-step worsening over time. Doctors usually start with a conversation about symptoms of aromatase deficiency, such as unusual genital development in a baby, delayed or unusual puberty, ongoing acne, excess body hair, or continued growth with delayed bone maturation. Diagnosis and follow-up usually involve hormone blood tests, imaging when needed, bone age checks, and sometimes genetic testing to confirm the cause.
Outlook and prognosis
The outlook for people with aromatase deficiency varies with the severity of hormone imbalance and how early the condition is recognized and treated. With appropriate endocrine care, many affected individuals can have good long-term outcomes, especially when treatment helps address abnormal pubertal development, bone health, fertility issues, and metabolic complications. Prognosis is generally improved by early diagnosis in aromatase deficiency because timely hormone management may reduce progressive bone age abnormalities, short stature risk, osteoporosis, and ongoing virilization in affected females. Fertility may be reduced, but reproductive outcomes depend on the specific clinical features and the effectiveness of hormone therapy. Life expectancy is not usually thought to be markedly shortened when the disorder is properly managed, and deaths directly attributable to aromatase deficiency have not been widely reported. Ongoing follow-up is important because untreated disease can lead to significant lifelong complications affecting growth, skeletal health, and reproductive function.
Long-term effects
Aromatase deficiency can affect growth, puberty, bones, fertility, and long-term hormone balance from childhood into adult life. In medical terms, these are sometimes called late effects or chronic symptoms. The pattern can look quite different depending on age, sex, and when the condition is recognized, so the long-term picture is often variable. For many living with aromatase deficiency, some changes are mainly physical, while others affect reproduction and metabolic health over time.
Many people with aromatase deficiency grow unusually tall for their family because bone growth plates may stay open longer than expected. In childhood or the teen years, this can show up as continued growth after peers have stopped growing and a longer arm span.
Puberty may be absent, delayed, or incomplete, especially in people who need estrogen for typical sexual development. Early symptoms of aromatase deficiency can include little breast development, lack of menstrual periods, or slower pubertal change than expected.
Low estrogen over many years can lead to thinner bones and lower bone strength. This may raise the risk of osteopenia, osteoporosis, and fractures in adolescence or adulthood.
Fertility can be reduced because normal estrogen levels are important for ovulation, menstrual cycles, and other parts of reproductive function. Some may also have enlarged ovaries or ovarian cysts over time.
How is it to live with Aromatase deficiency?
Living with aromatase deficiency often means managing the effects of very low estrogen over many years, and day-to-day life can include regular visits with hormone specialists, blood tests, and treatment to support puberty, bone strength, growth, and reproductive health. What this feels like can vary a lot: some people live with differences in sex development, delayed puberty, absent or irregular periods, fertility concerns, or bone pain and fractures, while others may notice fewer symptoms early on but still need monitoring as they grow. For families and partners, the condition can bring practical and emotional demands too, but with informed care and steady support, many people with aromatase deficiency can build healthy routines and plan for school, work, relationships, and future family decisions.
Treatment and drugs
For people living with aromatase deficiency, treatment is aimed at easing day-to-day symptoms and helping the body develop and function more normally over time. Because this condition causes very low estrogen levels, care often centers on hormone replacement, usually with estrogen, while doctors also monitor growth, bone strength, puberty, and reproductive health. In children and teens, treatment is adjusted carefully to support healthy development without causing unwanted side effects, and adults may need ongoing hormone treatment to protect bones and support sexual health. Not every treatment works the same way for every person, so follow-up visits and blood tests are important, especially when early symptoms of aromatase deficiency first lead to treatment. If the condition affects fertility, genital development, or hormone levels in a parent during pregnancy, care is often guided by a hormone specialist and may involve several doctors working together.
Can you cure Aromatase deficiency?
No, there is no cure for aromatase deficiency right now, and treatment cannot remove the underlying inherited change that causes it. But hormone treatment, often with estrogen, plus regular medical follow-up can help with growth and puberty, support bone health, and manage some symptoms.
Non-drug treatment
Day-to-day care for Aromatase deficiency often centers on growth, bone strength, movement, fertility planning, and emotional well-being. Managing this condition often means working with a team, because needs can change from childhood through adulthood. Non-drug treatment for aromatase deficiency is usually used alongside medical care, not in place of it. The best plan depends on age, symptoms, and whether bones, puberty, or fertility are being affected.
Regular follow-up with endocrinology and other specialists helps track growth, puberty, bone health, and reproductive health over time. This can help spot changes early and guide day-to-day care as needs shift.
Weight-bearing exercise, physical activity, and good intake of calcium and vitamin D can help support stronger bones. For many, this can mean walking, dancing, or simple strength work as part of a regular routine.
Physical therapy can help if weak bones, joint discomfort, or muscle weakness make movement harder. A tailored plan may improve balance, posture, and confidence with everyday activities.
Meeting with a dietitian can help if growth, weight, or bone nutrition is a concern. Structured programs, like personalized meal planning, can help build steady habits that support overall health.
Your genes may have an impact on how drugs work for you
For people living with aromatase deficiency, treatment often involves replacing missing sex hormones, and the dose may need to be adjusted because each body can respond a little differently. Right now, there is no well-established, routine use of extra genetic testing to predict exactly which medicine or dose will work best for this condition, so doctors usually guide treatment by how someone feels, growth and bone changes, and hormone blood test results. In day-to-day life, this can mean one person does well on a certain hormone dose while another needs it raised or lowered over time to avoid side effects and get the best benefit.
Pharmacological treatments
Treatment for aromatase deficiency usually centers on replacing the estrogen the body cannot make well enough. In daily life, this can help with delayed or absent puberty, bone strength, menstrual health, and some hormone-related symptoms, although needs differ by age and sex. Estradiol is the main medicine used, and doctors adjust the dose carefully over time. Not everyone responds to the same medication in the same way.
Estradiol is the main drug used to treat aromatase deficiency because it replaces the missing estrogen directly. It is often given as a pill, skin patch, or gel, with the dose raised slowly to support puberty, protect bones, and improve hormone balance.
In girls and women with aromatase deficiency, low-dose estradiol is commonly started and then increased step by step to encourage breast development, menstrual cycling, and bone health. This gradual approach is a key part of treatment for aromatase deficiency, especially when early symptoms of aromatase deficiency include delayed puberty or absent periods.
After puberty, estradiol is usually continued long term at a maintenance dose to help keep estrogen levels in a healthier range. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy).
Some boys and men with aromatase deficiency may also be treated with estradiol, especially to support bone maturation and reduce problems such as low bone density. Because hormone needs can vary, treatment is usually individualized and monitored with blood tests, growth or bone checks, and symptom follow-up.
Genetic influences
Aromatase deficiency is caused by changes in a gene called CYP19A1, which tells the body how to make the aromatase enzyme. This enzyme helps the body convert certain hormones into estrogen, so when it does not work properly, hormone balance can shift before birth and later in life. Aromatase deficiency is inherited in an autosomal recessive pattern, meaning a child usually develops it only if they receive one altered copy of the gene from each parent; parents are often healthy carriers and may not know they carry it. For many, this can mean there is no obvious family history until one child is diagnosed, although brothers or sisters may also be affected. Understanding whether aromatase deficiency is inherited can guide next steps, including genetic counseling and, in some families, testing for relatives.
Is Aromatase deficiency genetic?
Genetics are central to aromatase deficiency. It is usually caused by changes in the CYP19A1 gene, and different genetic variants can affect how severe aromatase deficiency is and when symptoms first appear.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common across the general population. Most of these variants do not have a direct impact on health and are simply part of natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Delayed puberty, irregular periods, or ongoing bone problems can make treatment decisions feel especially important for people with aromatase deficiency. The main genetic influence is the change in the CYP19A1 gene, which reduces or blocks the body’s ability to make estrogen, so treatment is aimed at replacing what is missing rather than using a one-size-fits-all approach. Most treatment for aromatase deficiency involves carefully adjusted estrogen therapy, especially to support puberty, bone strength, growth, and reproductive health, and some boys and men may also need low-dose estrogen to help bones mature normally. Not every difference in response is genetic, but in aromatase deficiency the gene change is the reason treatment is needed in the first place. Doctors usually tailor the type and dose of hormone treatment over time by watching symptoms, growth, hormone levels, and bone health, because even people with the same condition may need different plans. In this way, genetic testing does not just confirm the diagnosis of aromatase deficiency; it also helps guide the safest treatment for aromatase deficiency and long-term follow-up.
Interactions with other conditions
People living with aromatase deficiency often feel the effects beyond puberty or fertility, because very low estrogen can also affect bones and metabolism over time. In children and adults, aromatase deficiency can be linked with low bone density, which may raise the risk of osteopenia or osteoporosis and, later on, fractures. Some may also develop insulin resistance, abnormal blood sugar, or unhealthy cholesterol levels, so doctors may watch for type 2 diabetes and heart-related risk factors as part of routine care. Doctors call it a comorbidity when two conditions occur together. For many, this means care is not only about hormone levels, but also about checking bone strength, growth, weight, and metabolic health, since the pattern can differ between females and males and from one family to another. Early treatment and follow-up can help reduce the chance that these related health problems become more serious.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Aromatase deficiency?
Aromatase deficiency can be mistaken for other hormone conditions, especially congenital adrenal hyperplasia, which is an inherited condition that can cause high levels of male-type hormones, and polycystic ovary syndrome, which can also cause excess hair growth, acne, and irregular periods. Doctors may also look for hormone-making growths in the ovaries or adrenal glands, and for other conditions that affect sex development before birth when a baby is born with genitals that do not look typical. In males or adults with tall height, bones that keep growing longer than usual, or weak bones, other causes of very low estrogen and a rare problem where the body cannot respond to estrogen can look similar too.
History
For a long time, aromatase deficiency was not recognized as its own condition. Instead, doctors saw separate pieces of the picture: a baby born with genitals that looked different than expected, delayed or unusual puberty, or a woman who did not make estrogen in the usual way. Families may have been living with these patterns for years before medicine had the tools to connect them.
As medical science evolved, doctors began to realize that these signs could come from a problem with the body’s ability to make estrogen from other hormones. That helped explain why aromatase deficiency can affect development before birth, during childhood, and later in adult life. In some people, the earliest clues were seen at birth, while in others the first concerns appeared around puberty, such as lack of breast development, menstrual problems, ongoing growth, or bone health issues. In pregnancy, some mothers carrying an affected baby were also reported to develop symptoms linked to unusually high androgen levels, which gave doctors another important clue.
By the late 20th century, improved hormone testing and genetic research made it possible to describe aromatase deficiency more clearly. What had once seemed like a confusing mix of symptoms was understood as one rare hormonal condition with a shared underlying cause. This also helped doctors better recognize the early symptoms of aromatase deficiency and distinguish it from other conditions that can affect sex development or puberty.
Today, the history of aromatase deficiency is still fairly short compared with more common conditions, but knowledge has grown steadily. Doctors now understand much more about how low estrogen levels can affect growth, bones, fertility, and sexual development across different ages. That clearer picture has made diagnosis more accurate and has helped people with aromatase deficiency get more tailored care and support.